Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · IEX Real-Time Price · USD
0.683
+0.004 (0.60%)
At close: Apr 26, 2024, 4:00 PM
0.690
+0.007 (1.00%)
After-hours: Apr 26, 2024, 7:22 PM EDT
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $32.96 million as of April 26, 2024. Its market cap has decreased by -51.32% in one year.
Market Cap
32.96M
Enterprise Value
29.32M
1-Year Change
-51.32%
Ranking
Category
Stock Price
$0.68
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $32.96M, a decrease of -93.59%. That is a compound annual growth rate of -66.18%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 26, 2024 | 33.00M | 2.17% |
Apr 25, 2024 | 32.30M | -2.12% |
Apr 24, 2024 | 33.00M | -5.44% |
Apr 23, 2024 | 34.90M | -3.59% |
Apr 22, 2024 | 36.20M | -5.73% |
Apr 19, 2024 | 38.40M | -0.26% |
Apr 18, 2024 | 38.50M | -0.52% |
Apr 17, 2024 | 38.70M | -1.53% |
Apr 16, 2024 | 39.30M | 0.51% |
Apr 15, 2024 | 39.10M | 0.26% |
Apr 12, 2024 | 39.00M | -5.80% |
Apr 11, 2024 | 41.40M | -6.97% |
Apr 10, 2024 | 44.50M | - |
Apr 9, 2024 | 44.50M | 1.83% |
Apr 8, 2024 | 43.70M | -2.46% |
Apr 5, 2024 | 44.80M | -0.22% |
Apr 4, 2024 | 44.90M | 1.35% |
Apr 3, 2024 | 44.30M | 3.26% |
Apr 2, 2024 | 42.90M | -0.92% |
Apr 1, 2024 | 43.30M | 10.74% |
Mar 28, 2024 | 39.10M | -18.20% |
Mar 27, 2024 | 47.80M | - |
Mar 26, 2024 | 47.80M | -6.46% |
Mar 25, 2024 | 51.10M | 4.93% |
Mar 22, 2024 | 48.70M | -1.81% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Precision Optics Corporation | 33.77M |
electroCore | 33.49M |
Inspira Technologies Oxy B.H.N. | 33.38M |
Nutex Health | 33.29M |
SeaStar Medical Holding | 33.13M |
Viracta Therapeutics | 32.84M |
NRx Pharmaceuticals | 32.72M |
CASI Pharmaceuticals | 32.70M |